PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 22 filers reported holding PDL BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 9,702,000 | $10,272,000 | 20.58% |
| Pinnacle Holdings, LLC | 1,985,000 | $2,136,019,000 | 1.02% |
| Arkos Global Advisors | 34,000 | $37,000 | 0.02% |
| ENVESTNET ASSET MANAGEMENT INC | 30,000 | $32,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000,000 | $1,010,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 8 | $8,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 37,000 | $39,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |